10/29/2024 | Press release | Distributed by Public on 10/29/2024 15:28
| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price | | | | $ | | | | | $ | | | ||
Underwriting discounts and commissions(1) | | | | $ | | | | | $ | | | ||
Proceeds, before expenses, to the selling shareholders | | | | $ | | | | | $ | | | |
| | |
Page
|
| |||
FORWARD-LOOKING STATEMENTS
|
| | | | S-iii | | |
PROSPECTUS SUPPLEMENT SUMMARY
|
| | | | S-1 | | |
THE OFFERING
|
| | | | S-5 | | |
RISK FACTORS
|
| | | | S-7 | | |
USE OF PROCEEDS
|
| | | | S-9 | | |
SELLING SHAREHOLDERS
|
| | | | S-10 | | |
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
|
| | | | S-11 | | |
UNDERWRITING | | | | | S-15 | | |
VALIDITY OF COMMON STOCK
|
| | | | S-26 | | |
EXPERTS | | | | | S-26 | | |
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
|
| | | | S-27 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
|
| | | | 4 | | |
|
THE COMPANY
|
| | | | 6 | | |
|
RISK FACTORS
|
| | | | 8 | | |
|
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 2 | | |
|
USE OF PROCEEDS
|
| | | | 9 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 10 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 15 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 22 | | |
|
DESCRIPTION OF UNITS
|
| | | | 24 | | |
|
GLOBAL SECURITIES
|
| | | | 25 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 28 | | |
|
LEGAL MATTERS
|
| | | | 30 | | |
| EXPERTS | | | | | 30 | | |
Name of Selling
Shareholder |
| |
Shares Beneficially
Owned Prior to Offering(1) |
| |
Shares
Offered |
| |
Shares Beneficially
Owned After Offering Assuming the Underwriter's Option to Purchase Additional Shares is Not Exercised(2) |
| |
Additional
Shares Offered if Option to Purchase Additional Shares is Exercised in Full |
| |
Shares Beneficially
Owned After Offering if the Underwriter's Option to Purchase Additional Shares is Exercised in Full(2) |
| |||||||||||||||||||||||||||||||||
|
Number
|
| |
Percentage
|
| |
Number
|
| |
Percentage
|
| |
Number
|
| |
Percentage
|
| ||||||||||||||||||||||||||||||||
Marshman Fund Trust II(3)
|
| | | | 10,651,120 | | | | | | 18.7% | | | | | | 4,000,000 | | | | | | 6,651,120 | | | | | | 11.7% | | | | | | 600,000 | | | | | | 6,051,120 | | | | | | 10.6% | | |
Valor IV Pharma Holdings, LLC(4)
|
| | | | 11,218,033 | | | | | | 19.7% | | | | | | 4,000,000 | | | | | | 7,218,033 | | | | | | 12.7% | | | | | | 600,000 | | | | | | 6,618,033 | | | | | | 11.6% | | |
Name
|
| |
Number of Shares
|
|
J.P. Morgan Securities LLC
|
| | | |
Total
|
| | | |
|
| | |
Without
option to purchase additional shares exercise |
| |
With full
option to purchase additional shares exercise |
| ||||||
Per Share
|
| | | $ | | | | | $ | | | ||
Total
|
| | | $ | | | | | $ | | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
|
| | | | 4 | | |
|
THE COMPANY
|
| | | | 6 | | |
|
RISK FACTORS
|
| | | | 8 | | |
|
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 2 | | |
|
USE OF PROCEEDS
|
| | | | 9 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 10 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 15 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 22 | | |
|
DESCRIPTION OF UNITS
|
| | | | 24 | | |
|
GLOBAL SECURITIES
|
| | | | 25 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 28 | | |
|
LEGAL MATTERS
|
| | | | 30 | | |
|
EXPERTS
|
| | | | 30 | | |